# OnCo record genocury-biotech (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/genocury-biotech/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "genocury-biotech" ;
  schema:name "Genocury Biotech"@en ;
  schema:alternateName "Shenzhen Genocury Biotech Co., Ltd."@en, "济因生物"@en, "Genocury"@en ;
  schema:description "Genocury Biotech, in Shenzhen, is testing CAR-T treatments made inside the patient's body from a single infusion, rather than in a laboratory, for lymphoma, leukaemia and myeloma. The trials are early and run by hospital investigators in China."@en ;
  schema:url <https://onco.cc/companies/genocury-biotech/>, <https://genocury.com/> ;
  schema:dateModified "2026-11-04"^^xsd:date ;
  schema:citation <https://genocury.com/>, <https://clinicaltrials.gov/study/NCT06678282>, <https://www.1stoncology.com/blog/?p=102826>, <https://www.orbimed.com/portfolio/> ;
  schema:addressCountry "CN" ;
  onco:cancers <https://onco.cc/cancers/non-hodgkin-lymphoma/>, <https://onco.cc/cancers/dlbcl/>, <https://onco.cc/cancers/all-leukemia/>, <https://onco.cc/cancers/multiple-myeloma/> ;
  onco:sections <https://onco.cc/fronts/cell-therapy/>, <https://onco.cc/fronts/immunotherapy/> ;
  onco:technologies <https://onco.cc/technologies/in-vivo-car-t/>, <https://onco.cc/technologies/car-t/> ;
  onco:targets <https://onco.cc/targets/cd19/> ;
  onco:drugs <https://onco.cc/drugs/jy231/>, <https://onco.cc/drugs/jy232/> .